Cargando…
MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimens
O6-methylguanine-DNA methyltransferase (MGMT) has been linked with alkylating agent resistance and tumor growth suppression. However, its role remains undetermined in pancreatic neuroendocrine tumors (Pan-NET). The MGMT expression was examined by immunohistochemistry in 142 patients to evaluate MGMT...
Autores principales: | Yagi, Kohei, Ono, Hiroaki, Kudo, Atsushi, Kinowaki, Yuko, Asano, Daisuke, Watanabe, Shuichi, Ishikawa, Yoshiya, Ueda, Hiroki, Akahoshi, Keiichi, Tanaka, Shinji, Tanabe, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170117/ https://www.ncbi.nlm.nih.gov/pubmed/37161026 http://dx.doi.org/10.1038/s41598-023-34666-y |
Ejemplares similares
-
Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma
por: Yagi, Kohei, et al.
Publicado: (2023) -
Pancreatic metastasis from renal cell carcinoma presenting as gastrointestinal hemorrhage: a case report
por: Matsui, Satoshi, et al.
Publicado: (2021) -
Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer
por: Ishii, Takeshi, et al.
Publicado: (2022) -
RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer
por: Ono, Hiroaki, et al.
Publicado: (2023) -
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms
por: Murase, Yoshiki, et al.
Publicado: (2021)